← Back to Search

Behavioral Intervention

Online Program for Endometriosis Pain

N/A
Waitlist Available
Led By Caroline Pukall, PhD
Research Sponsored by Queen's University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months after the end of the program
Awards & highlights

Study Summary

This trial will measure the effectiveness of an online program for treating endometriosis pain. Participants must be 18+, speak English, and have been diagnosed for 3+ months. All aspects of the trial will be done online.

Who is the study for?
This trial is for adults over 18 who speak English and have been diagnosed with endometriosis, experiencing pain for at least three months. Participants will continue their usual treatment while being involved in the study.Check my eligibility
What is being tested?
The PelvicSense online program's effectiveness on reducing pain and improving sexual outcomes in individuals with endometriosis is being tested. The study spans over a period of six months including assessments before, after the 3-month program, and a follow-up.See study design
What are the potential side effects?
Since PelvicSense is an educational intervention rather than a medication, it may not have typical drug side effects; however, participants might experience discomfort or emotional distress when addressing sensitive topics.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months after the end of the program
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months after the end of the program for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain intensity
Secondary outcome measures
Pain catastrophizing
Other outcome measures
Pain self-efficacy
Sexual distress

Trial Design

1Treatment groups
Experimental Treatment
Group I: 3 month PelvicSense(R) programExperimental Treatment1 Intervention
PelvicSense® is a home-based physiotherapy program integrating multiple techniques, including relaxation, breathing, stretching, strengthening and at-home manual therapy. This program also educates participants about the anatomy and physiology of the pelvis and teaches strategies to strengthen the mind-muscle connection to the pelvis.

Find a Location

Who is running the clinical trial?

Queen's UniversityLead Sponsor
365 Previous Clinical Trials
120,367 Total Patients Enrolled
Caroline Pukall, PhDPrincipal InvestigatorQueen's University
3 Previous Clinical Trials
95 Total Patients Enrolled

Media Library

PelvicSense(R) (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05909579 — N/A
Endometriosis Research Study Groups: 3 month PelvicSense(R) program
Endometriosis Clinical Trial 2023: PelvicSense(R) Highlights & Side Effects. Trial Name: NCT05909579 — N/A
PelvicSense(R) (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05909579 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment still open for this research project?

"The data on clinicaltrials.gov suggests that this medical trial is no longer enrolling patients; the posting was initially listed June 1st 2023 and last updated on June 8th, 2023. Nevertheless, there are currently 93 other studies actively recruiting participants at this time."

Answered by AI
~11 spots leftby Aug 2024